Literature DB >> 14967416

Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.

Wayne L Chandler1, Tomas Velan.   

Abstract

INTRODUCTION: Cardiopulmonary bypass (CPB) is associated with elevated tissue plasminogen activator (t-PA) levels during CPB and increased plasminogen activator inhibitor 1 (PAI-1) levels post-operatively. The goal of this study was to estimate the rate of t-PA and PAI-1 secretion in vivo, before, during and after CPB.
MATERIALS AND METHODS: Estimated rates of t-PA and PAI-1 secretion were based on measured levels of active and total t-PA, and active and total PAI-1, obtained before, during and after CPB from nine males, combined with a computer model of each patient's vascular system that continuously accounted for secretion, clearance, hemodilution, blood loss and transfusion. RESULTS AND
CONCLUSIONS: At baseline, the average t-PA and PAI-1 secretion rates were 0.74+/-0.33 and 1.28+/-0.74 pmol/s, respectively. Within 5 min of CPB initiation, t-PA secretion increased six-fold to 4.41+/-2.58 pmol/s, while PAI-1 secretion was unchanged, resulting in a six-fold increase in active t-PA levels. t-PA secretion remained elevated throughout CPB and into the early post-operative period. Average PAI-1 secretion did not start to increase until the end of CPB. By 2 h after surgery, average PAI-1 secretion had increased 15-fold to 19.60+/-17.10 pmol/s, resulting in reduced levels of active t-PA even though t-PA secretion was still elevated. We conclude that CPB induces an immediate sustained increase in t-PA secretion followed by a delayed progressive increase in PAI-1 production. Variations in the level of active t-PA are a function of the relative rates of t-PA versus PAI-1 secretion at different times during and after surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14967416     DOI: 10.1016/j.thromres.2003.11.006

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

Review 1.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

2.  Blood management-issues: the panic of coagulopathic bleeding--is there a rational approach?

Authors:  Bruce D Spiess
Journal:  J Extra Corpor Technol       Date:  2011-03

Review 3.  Antifibrinolytics and cardiac surgery: The past, the present, and the future.

Authors:  Naresh K Aggarwal; Arun Subramanian
Journal:  Ann Card Anaesth       Date:  2020 Apr-Jun

4.  Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.

Authors:  Zhen-Feng Zhou; Wen Zhai; Li-Na Yu; Kai Sun; Li-Hong Sun; Xiu-Fang Xing; Min Yan
Journal:  BMC Anesthesiol       Date:  2021-02-02       Impact factor: 2.217

5.  Postoperative Pulmonary Hemodynamics and Systemic Inflammatory Response in Pediatric Patients Undergoing Surgery for Congenital Heart Defects.

Authors:  Maria Francilene S Souza; Juliano G Penha; Nair Y Maeda; Filomena R B G Galas; Kelly C O Abud; Eloisa S Carvalho; Ana Maria Thomaz; Claudia R P Castro; Juliana Pereira; Antonio Augusto Lopes
Journal:  Mediators Inflamm       Date:  2022-01-15       Impact factor: 4.711

Review 6.  Pharmacological management of perioperative bleeding in cardiac surgery.

Authors:  Hossam Walley; Magdi Yacoub; Hesham Saad
Journal:  Glob Cardiol Sci Pract       Date:  2017-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.